Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Makoto, Nakagawa"'
Autor:
Ga I. Ban, Vijitha Puviindran, Yu Xiang, Puvi Nadesan, Jackie Tang, Jianhong Ou, Nicholas Guardino, Makoto Nakagawa, MaKenna Browne, Asjah Wallace, Koji Ishikawa, Eijiro Shimada, John T. Martin, Yarui Diao, David G. Kirsch, Benjamin A. Alman
Publikováno v:
iScience, Vol 27, Iss 7, Pp 110187- (2024)
Summary: Intratumoral heterogeneity is common in cancer, particularly in sarcomas like undifferentiated pleomorphic sarcoma (UPS), where individual cells demonstrate a high degree of cytogenic diversity. Previous studies showed that a small subset of
Externí odkaz:
https://doaj.org/article/144907bc7fea4fa9bea54a2af2dc7bf3
Autor:
Haruka Shinohara, Rie Sawado, Makoto Nakagawa, Ayuna Hattori, Kazutsune Yamagata, Kimiharu Tauchi, Jumpei Ito, Yasumichi Kuwahara, Tsukasa Okuda, Chitose Ogawa, Issay Kitabayashi
Publikováno v:
Molecular Therapy: Oncolytics, Vol 27, Iss , Pp 14-25 (2022)
Malignant rhabdoid tumors (MRTs) are rare and highly aggressive pediatric cancers with no standard of care. MRTs are characterized by loss of SMARCB1, which results in upregulated expression of enhancer of zeste homolog 2 (EZH2), which is responsible
Externí odkaz:
https://doaj.org/article/20b4e9bb9f2b401e9e56e32a3e37b927
Autor:
Atsushi Kimura, Yu Toda, Yoshihiro Matsumoto, Hidetaka Yamamoto, Kenichiro Yahiro, Eijiro Shimada, Masaya Kanahori, Ryunosuke Oyama, Suguru Fukushima, Makoto Nakagawa, Nokitaka Setsu, Makoto Endo, Toshifumi Fujiwara, Tomoya Matsunobu, Yoshinao Oda, Yasuharu Nakashima
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Denosumab is a game-changing drug for giant cell tumor of bone (GCTB); however, its clinical biomarker regarding tumor ossification of GCTB has not been elucidated. In this study, we investigated the relationship between Wnt/β-catenin signa
Externí odkaz:
https://doaj.org/article/2526be36ad6e453689fbdff8d810659c
Autor:
Sinthu Pathmanapan, Raymond Poon, Tomasa Barrientos De Renshaw, Puviindran Nadesan, Makoto Nakagawa, Gireesh A. Seesankar, Adrian Kwan Ho Loe, Hongyuan H. Zhang, Joan J. Guinovart, Jordi Duran, Christopher B. Newgard, Jay S. Wunder, Benjamin A. Alman
Publikováno v:
Cell Reports, Vol 42, Iss 6, Pp 112578- (2023)
Summary: Chondrosarcomas are the most common malignancy of cartilage and are associated with somatic mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 genes. Somatic IDH mutations are also found in its benign precursor lesion, enchondromas, sug
Externí odkaz:
https://doaj.org/article/9cb3c9ca6c2240379dd61634e40c1c8c
Autor:
Makoto Nakagawa, Eisuke Kobayashi, Masayoshi Yamada, Tomoko Watanabe, Makoto Hirata, Noriko Tanabe, Mineko Ushiama, Hiromi Sakamoto, Chiaki Sato, Taisuke Mori, Akihiko Yoshida, Teruhiko Yoshida, Kokichi Sugano, Akira Kawai
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-7 (2021)
Abstract Background Muir–Torre syndrome (MTS), which accounts for a small subset (1–3 %) of Lynch syndrome (LS), is an autosomal dominant genetic disorder characterized by sebaceous gland or keratoacanthoma associated with visceral malignancies.
Externí odkaz:
https://doaj.org/article/043b2434e9e943459da97a220dbdb95a
Autor:
Makoto Nakagawa, Masayuki Yamaguchi, Makoto Endo, Yukino Machida, Ayuna Hattori, Fumie Tanzawa, Shinji Tsutsumi, Issay Kitabayashi, Akira Kawai, Fumihiko Nakatani
Publikováno v:
Journal of Bone Oncology, Vol 34, Iss , Pp 100430- (2022)
Background: Chondrosarcoma is a common form of malignant bone tumor with limited treatment options. Approximately half of chondrosarcomas harbor gain-of-function mutations in isocitrate dehydrogenase (IDH), and mutant IDH produces 2-hydroxyglutarate
Externí odkaz:
https://doaj.org/article/2608c96933974fcbb235adc9d90b84cb
Autor:
Rie Kakehashi, Naoji Tokai, Makoto Nakagawa, Kazunori Kawasaki, Shin Horiuchi, Atsushi Yamamoto
Publikováno v:
Gels, Vol 9, Iss 3, p 261 (2023)
Rheology control is an important issue in many industrial products such as cosmetics and paints. Recently, low-molecular-weight compounds have attracted considerable attention as thickeners/gelators for various solvents; however, there is still a sig
Externí odkaz:
https://doaj.org/article/5b1ece9dc8aa4227a2fad448daa0616e
Publikováno v:
Bulletin of the Chemical Society of Japan; Jul2024, Vol. 97 Issue 7, p1-9, 9p
Autor:
Kotaro Nochioka, Yasuhiko Sakata, Masanobu Miura, Takashi Shiroto, Jun Takahashi, Chie Saga, Yasuko Ikeno, Nobuyuki Shiba, Tsuyoshi Shinozaki, Masafumi Sugi, Makoto Nakagawa, Tatsuya Komaru, Atsushi Kato, Eiji Nozaki, Kaoru Iwabuchi, Tetsuya Hiramoto, Kanichi Inoue, Masatoshi Ohe, Kenji Tamaki, Ichiro Tsuji, Hiroaki Shimokawa
Publikováno v:
ESC Heart Failure, Vol 6, Iss 6, Pp 1252-1261 (2019)
Abstract Aims The study aims to evaluate the prognostic significance of impaired glucose tolerance (IGT) with reference to albuminuria in patients with chronic heart failure (CHF). Methods and results We examined 535 CHF patients (mean 66 years, wome
Externí odkaz:
https://doaj.org/article/3da08613601c4c2d9dee2972db2617cb
Autor:
Eisuke Kobayashi, Suguru Fukushima, Shintaro Iwata, Fumihiko Nakatani, Makoto Nakagawa, Issay Kitabayashi, Masaya Sekimizu, Makoto Endo, Akira Kawai, Hitoshi Ichikawa, Akihiko Yoshida
Publikováno v:
Journal of Orthopaedic Science. 27:1315-1322
Mutant isocitrate dehydrogenase (IDH) in chondrosarcoma produces the oncometabolite 2-hydroxyglutarate (2-HG) and contributes to malignant progression, and is therefore a potential therapeutic target for chondrosarcoma. Robust historical control data